Asia Pacific Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Type (Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs), By Distribution Channel, By Age, By Country and Growth Forecast, 2024

List of Tables

The Asia Pacific Huntington's Disease Treatment Market would witness market growth of 9.7% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Huntington's Disease Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $55,605.8 Thousands by 2031. The Japan market is registering a CAGR of 9% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 10.4% during (2024 - 2031).

Information on HD, its signs and symptoms, accessible treatments, and support services gives patients and carers the power to take an active role in their care and make educated decisions. HD can affect swallowing and speech abilities. Nutritional counseling and speech therapy help manage these challenges and maintain overall health.

Emerging neuroprotective strategies aim to preserve neuronal function, protect against neurodegeneration, and potentially delay disease onset or progression. Therapies targeting oxidative stress, mitochondrial function, and other neuroprotective mechanisms aim to enhance neuronal resilience and slow disease progression. Experimental approaches using stem cells to replace damaged neurons and promote neural regeneration are being explored for their potential to restore brain function in HD patients.

As the hospital sector expands in India, there is greater potential for establishing specialized neurology departments and clinics equipped to diagnose and manage complex neurological conditions like Huntington's disease. The hospital sector in India, which makes up 80% of the country's healthcare business overall, is seeing strong investment demand from domestic and foreign investors, according to the National Investment Promotion and Facilitation Agency of India. The healthcare industry was expected to rise to $132 billion by 2023. In addition, Australia's high prevalence of HD encourages focused genetic research to understand the disease's underlying mechanisms and identify potential therapeutic targets. According to the Australian Government, the prevalence rate of Huntington's disease was estimated at 8.4 per 100,000 people (about 2,160 people). About 830 people diagnosed with Huntington's disease received a National Disability Insurance Scheme (NDIS) package on 31 December 2019. Hence, the rising hospital sector and the prevalence of HD are driving the market's growth.

Based on Drug Type, the market is segmented into Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Store & Retail Pharmacies, and Online Pharmacies. Based on Age, the market is segmented into Below 50 years and Above 50 years. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

Bausch Health Companies, Inc.
Teva Pharmaceutical Industries Ltd.
Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
Hikma Pharmaceuticals PLC
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Neurocrine Biosciences Inc.
Pfizer, Inc.
F. Hoffmann-La Roche Ltd.

Asia Pacific Huntington's Disease Treatment Market Report Segmentation

By Drug Type

Approved Drugs
- Tetrabenazine
- Deutetrabenazine
Offlabel Drugs

By Distribution Channel

Hospital Pharmacies
Drug Store & Retail Pharmacies
Online Pharmacies

By Age

Below 50 years
Above 50 years

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Huntington's Disease Treatment Market, by Drug Type
- 1.4.2 Asia Pacific Huntington's Disease Treatment Market, by Distribution Channel
- 1.4.3 Asia Pacific Huntington's Disease Treatment Market, by Age
- 1.4.4 Asia Pacific Huntington's Disease Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Huntington's Disease Treatment Market by Drug Type

4.1 Asia Pacific Approved Drugs Market by Country
4.2 Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type
- 4.2.1 Asia Pacific Tetrabenazine Market by Country
- 4.2.2 Asia Pacific Deutetrabenazine Market by Country
4.3 Asia Pacific Offlabel Drugs Market by Country

Chapter 5. Asia Pacific Huntington's Disease Treatment Market by Distribution Channel

5.1 Asia Pacific Hospital Pharmacies Market by Country
5.2 Asia Pacific Drug Store & Retail Pharmacies Market by Country
5.3 Asia Pacific Online Pharmacies Market by Country

Chapter 6. Asia Pacific Huntington's Disease Treatment Market by Age

6.1 Asia Pacific Below 50 years Market by Country
6.2 Asia Pacific Above 50 years Market by Country

Chapter 7. Asia Pacific Huntington's Disease Treatment Market by Country

7.1 China Huntington's Disease Treatment Market
- 7.1.1 China Huntington's Disease Treatment Market by Drug Type
  - 7.1.1.1 China Huntington's Disease Treatment Market by Approved Drugs Type
- 7.1.2 China Huntington's Disease Treatment Market by Distribution Channel
- 7.1.3 China Huntington's Disease Treatment Market by Age
7.2 Japan Huntington's Disease Treatment Market
- 7.2.1 Japan Huntington's Disease Treatment Market by Drug Type
  - 7.2.1.1 Japan Huntington's Disease Treatment Market by Approved Drugs Type
- 7.2.2 Japan Huntington's Disease Treatment Market by Distribution Channel
- 7.2.3 Japan Huntington's Disease Treatment Market by Age
7.3 India Huntington's Disease Treatment Market
- 7.3.1 India Huntington's Disease Treatment Market by Drug Type
  - 7.3.1.1 India Huntington's Disease Treatment Market by Approved Drugs Type
- 7.3.2 India Huntington's Disease Treatment Market by Distribution Channel
- 7.3.3 India Huntington's Disease Treatment Market by Age
7.4 South Korea Huntington's Disease Treatment Market
- 7.4.1 South Korea Huntington's Disease Treatment Market by Drug Type
  - 7.4.1.1 South Korea Huntington's Disease Treatment Market by Approved Drugs Type
- 7.4.2 South Korea Huntington's Disease Treatment Market by Distribution Channel
- 7.4.3 South Korea Huntington's Disease Treatment Market by Age
7.5 Singapore Huntington's Disease Treatment Market
- 7.5.1 Singapore Huntington's Disease Treatment Market by Drug Type
  - 7.5.1.1 Singapore Huntington's Disease Treatment Market by Approved Drugs Type
- 7.5.2 Singapore Huntington's Disease Treatment Market by Distribution Channel
- 7.5.3 Singapore Huntington's Disease Treatment Market by Age
7.6 Malaysia Huntington's Disease Treatment Market
- 7.6.1 Malaysia Huntington's Disease Treatment Market by Drug Type
  - 7.6.1.1 Malaysia Huntington's Disease Treatment Market by Approved Drugs Type
- 7.6.2 Malaysia Huntington's Disease Treatment Market by Distribution Channel
- 7.6.3 Malaysia Huntington's Disease Treatment Market by Age
7.7 Rest of Asia Pacific Huntington's Disease Treatment Market
- 7.7.1 Rest of Asia Pacific Huntington's Disease Treatment Market by Drug Type
  - 7.7.1.1 Rest of Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type
- 7.7.2 Rest of Asia Pacific Huntington's Disease Treatment Market by Distribution Channel
- 7.7.3 Rest of Asia Pacific Huntington's Disease Treatment Market by Age

Chapter 8. Company Profiles

8.1 Dr. Reddy's Laboratories Ltd.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
8.2 Takeda Pharmaceutical Company Limited
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
8.3 Sun Pharmaceutical Industries Ltd.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
8.4 Hikma Pharmaceuticals PLC
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expenses
8.5 Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
- 8.5.1 Company Overview
8.6 Teva Pharmaceutical Industries Ltd.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
8.7 Bausch Health Companies, Inc
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 Neurocrine Biosciences Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Research & Development Expenses
8.9 Pfizer, Inc.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional & Segmental Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
8.10. F. Hoffmann-La Roche Ltd.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 Asia Pacific Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 2 Asia Pacific Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 3 Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 4 Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 5 Asia Pacific Approved Drugs Market by Country, 2020 - 2023, USD Thousands
TABLE 6 Asia Pacific Approved Drugs Market by Country, 2024 - 2031, USD Thousands
TABLE 7 Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 8 Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 9 Asia Pacific Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
TABLE 10 Asia Pacific Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
TABLE 11 Asia Pacific Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
TABLE 12 Asia Pacific Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
TABLE 13 Asia Pacific Offlabel Drugs Market by Country, 2020 - 2023, USD Thousands
TABLE 14 Asia Pacific Offlabel Drugs Market by Country, 2024 - 2031, USD Thousands
TABLE 15 Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 16 Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 17 Asia Pacific Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 18 Asia Pacific Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 19 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 20 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 21 Asia Pacific Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 22 Asia Pacific Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 23 Asia Pacific Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 24 Asia Pacific Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 25 Asia Pacific Below 50 years Market by Country, 2020 - 2023, USD Thousands
TABLE 26 Asia Pacific Below 50 years Market by Country, 2024 - 2031, USD Thousands
TABLE 27 Asia Pacific Above 50 years Market by Country, 2020 - 2023, USD Thousands
TABLE 28 Asia Pacific Above 50 years Market by Country, 2024 - 2031, USD Thousands
TABLE 29 Asia Pacific Huntington's Disease Treatment Market by Country, 2020 - 2023, USD Thousands
TABLE 30 Asia Pacific Huntington's Disease Treatment Market by Country, 2024 - 2031, USD Thousands
TABLE 31 China Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 32 China Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 33 China Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 34 China Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 35 China Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 36 China Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 37 China Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 38 China Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 39 China Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 40 China Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 41 Japan Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 42 Japan Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 43 Japan Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 44 Japan Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 45 Japan Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 46 Japan Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 47 Japan Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 48 Japan Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 49 Japan Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 50 Japan Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 51 India Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 52 India Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 53 India Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 54 India Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 55 India Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 56 India Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 57 India Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 58 India Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 59 India Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 60 India Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 61 South Korea Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 62 South Korea Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 63 South Korea Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 64 South Korea Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 65 South Korea Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 66 South Korea Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 67 South Korea Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 68 South Korea Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 69 South Korea Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 70 South Korea Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 71 Singapore Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 72 Singapore Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 73 Singapore Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 74 Singapore Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 75 Singapore Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 76 Singapore Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 77 Singapore Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 78 Singapore Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 79 Singapore Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 80 Singapore Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 81 Malaysia Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 82 Malaysia Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 83 Malaysia Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 84 Malaysia Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 85 Malaysia Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 86 Malaysia Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 87 Malaysia Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 88 Malaysia Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 89 Malaysia Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 90 Malaysia Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 91 Rest of Asia Pacific Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
TABLE 92 Rest of Asia Pacific Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
TABLE 93 Rest of Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
TABLE 94 Rest of Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
TABLE 95 Rest of Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
TABLE 96 Rest of Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
TABLE 97 Rest of Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 98 Rest of Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 99 Rest of Asia Pacific Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
TABLE 100 Rest of Asia Pacific Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
TABLE 101 Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 102 Key Information - Takeda Pharmaceutical Company Limited
TABLE 103 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 104 Key Information - Hikma Pharmaceuticals PLC
TABLE 105 Key Information - Camber Pharmaceuticals, Inc.
TABLE 106 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 107 key information - Bausch Health Companies, Inc.
TABLE 108 Key Information - Neurocrine Biosciences Inc.
TABLE 109 Key Information - Pfizer, Inc.
TABLE 110 Key Information - F. Hoffmann-La Roche Ltd.

Asia Pacific Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Type (Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs), By Distribution Channel, By Age, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents